ODeSI publications
Travel medicine and vaccines
Rafferty AC, Bofkin K, Hughes W, Souter S, Hosegood I, Hall RN, Furuya-Kanamori L, Liu B, Regan T, Drane M, Halder M, Kelaher C, Kirk M. Does 2x2 airplane passenger contact tracing for infectious respiratory pathogens work? A systematic review of the evidence. PLoS One 2023; [Epub ahead of print]
McGuinness, S. L., Lau, C. L., & Leder, K. (2023). Co-circulation of Murray-Valley Encephalitis Virus and Japanese Encephalitis Virus in south-eastern Australia. Journal of Travel Medicine. doi:10.1093/jtm/taad059
Guo, Y., Mills, D. J., Lau, C. L., Mills, C., & Furuya‐Kanamori, L. (2023). Immune response after rabies pre‐exposure prophylaxis and a booster dose in Australian bat carers. Zoonoses and Public Health. doi:10.1111/zph.13048
Furuya-Kanamori L, Gyawali N, Mills DJ, Hugo LE, Devine GJ, Lau CL. The Emergence of Japanese Encephalitis in Australia and the Implications for a Vaccination Strategy. Tropical Medicine and Infectious Disease. 2022;7(6).
Sinclair JE, Mayfield HJ, Short KR, Brown SJ, Puranik R, Mengersen K, Litt JCB, Lau CL. A Bayesian network analysis quantifying risks versus benefits of the Pfizer COVID-19 vaccine in Australia, npj Vaccines
Laith Yakob, PhD, Wenbiao Hu, PhD, Francesca D Frentiu, PhD, Narayan Gyawali, PhD, Leon E Hugo, PhD, Brian Johnson, PhD, Colleen Lau, MBBS, PhD, Luis Furuya-Kanamori, MBBS, PhD, Ricardo Soares Magalhaes, LMV, PhD, Gregor Devine, PhD, Japanese encephalitis emergence in Australia: the potential population at risk, Clinical Infectious Diseases, 2022;, ciac794, https://doi.org/10.1093/cid/ciac794
Luis Furuya-Kanamori, PhD, Narayan Gyawali, PhD, Deborah J Mills MBBS MPHTM, Christine Mills, BSc, Leon E Hugo, PhD, Gregor J Devine, PhD, Colleen L Lau, MBBS, Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine, Journal of Travel Medicine, 2022, https://doi.org/10.1093/jtm/taac122
McHugh L, Van Buynder P, Sarna M, Andrews RM, Moore HC, Binks MJ, Pereira G, Blyth CC, Lust K, Foo D, Regan AK. Timing and temporal trends of influenza and pertussis vaccinations during pregnancy in three Australian jurisdictions: The Links2HealthierBubs population-based linked cohort study, 2012–2017. ANZJOG. 2022; Epub13June 2022. doi.org/10.1111/ajo.13548.
Wattiaux AL, May F, Allen T, Bladen T, Pery B, McHugh L, Slinko V, Sykes A, De Silva L, Bajra J, Andrews R, Khandaker G. Defining the peak: Point prevalence of SARS-CoV-2 using randomised sampling. Comm Diseases Intel.2022;46.doi: 10.33321/cdi.2022.46.24. Epub 26/4/2022
Homaira N, Binks M, Walker G, Larter N, Clark K, Campbell M, McHugh L, Briggs N, Nyiro J, Stelzer-Braid S, Hu N, Macartney K,Snelling T, Omer SB, Rawlinson W, Andrews R, Jaffe A.Transplacental transfer of RSV antibody in Australian First Nations infants. (Short communication) Journal of Medical Virology. 2021. doi: 10.1002/jmv.27383
Furuya-Kanamori L, Xu C, Doi SAR, Clark J, Wangdi K, Mills DJ, Lau CL. Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis. Vaccine. 2021;39(32):4429-36. doi: https://doi.org/10.1016/j.vaccine.2021.06.023.
McHugh L, O’Grady KA-F, Nolan T, Richmond PC, Wood N, Marshall HS, Lambert SB, Chatfield MD, Paula Binks, Binks MJ, Andrews RM. 2021. National predictors of influenza vaccine uptake in pregnancy: The FluMum study, Australia, 2012-2015. Australian & New Zealand Journal of Obstetrics & Gynaecology. 45(5): 455-61. doi: https://doi.org/10.1111/1753-6405.13130
Mills DJ, Lau CL, Mills C, Furuya-Kanamori L. Efficacy of one-dose intramuscular rabies vaccine as pre-exposure prophylaxis in travellers. Journal of Travel Medicine. 2021;28(5). doi: 10.1093/jtm/taab059.
Ling W, Doi SAR, Lau CL, Mills DJ, Kostoulas P, Furuya-Kanamori L. Diagnostic accuracy of ELISA kits for measurement of rabies antibodies. Journal of Travel Medicine. 2021;28(5). doi: 10.1093/jtm/taab060.
Islam N, Wright S, Lau CL, Doi SAR, Mills DJ, Clark J, Clements ACA, Furuya-Kanamori L. Efficacy of a 3-day pretravel schedule of tafenoquine for malaria chemoprophylaxis: a network meta-analysis. Journal of Travel Medicine. 2021;28(5). doi: 10.1093/jtm/taab057.
Xu C, Lau CL, Clark J, Rafferty AC, Mills DJ, Ramsey L, Gilbert B, Doi SAR, Furuya-Kanamori L. Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis. Vaccine. 2021;39(7):1044-50. doi: https://doi.org/10.1016/j.vaccine.2021.01.023.
Furuya-Kanamori L, Dutton P, Leeb A, Mills DJ, Andrews R, Lau CL. Adverse Events Following Immunization With Combined vs Concurrent Monovalent Hepatitis A and Typhoid Vaccines in Children. Journal of the Pediatric Infectious Diseases Society. 2020;10(2):192-5. doi: 10.1093/jpids/piaa031.
Furuya-Kanamori L, Mills DJ, Lau CL. Could intradermal be an economical alternative route of administration for Japanese encephalitis vaccines? Journal of Travel Medicine. 2020;28(1). doi: 10.1093/jtm/taaa181.
McFadden K, Heywood A, Dyda A, Kaufman J, Seale H. Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution? Vaccine. 2021;39(26):3467-72. Epub 2021/05/25. doi: 10.1016/j.vaccine.2021.05.027. PubMed PMID: 34024659.
Heywood A, Dyda A, Hu W, Saha A, Mahimbo A, Gidding H, Kefalas B, Seale H, Macintyre CR, Zwar N, Rawlinson W. Seroprevalence of hepatitis B antibodies among international and domestic university students. Journal of Viral Hepatitis. 2021;28(10):1400-12. doi: https://doi.org/10.1111/jvh.13580.
Furuya-Kanamori L, Mills DJ, Trembizki E, Robson JM, Jennison AV, Whiley DM, Lau CL. High rate of asymptomatic colonization with antimicrobial-resistant Escherichia coli in Australian returned travellers. J Travel Med. 2022;29(1). Epub 2021/09/09. doi: 10.1093/jtm/taab141. PubMed PMID: 34494119.
Wen SCH, Ezure Y, Rolley L, Spurling G, Lau CL, Riaz S, Paterson DL, Irwin AD. Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis. PLOS Medicine. 2021;18(9):e1003787. doi: 10.1371/journal.pmed.1003787.
Mills DJ, Lau CL, Mills C, Furuya-Kanamori L. Long-term persistence of antibodies and boostability after rabies intradermal pre-exposure prophylaxis. Journal of Travel Medicine. 2021. doi: 10.1093/jtm/taab188.
Emerging infectious diseases
Sarah L. McGuinness, Colleen Lau, Karin Leder, The evolving Japanese encephalitis situation in Australia and implications for travel medicine, Journal of Travel Medicine, 2023
Nilles E, de St. Aubin M, Dumas D, Duke W, Etienne MC, Abdalla G, et al. Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021–August 2022. Emerging Infectious Disease journal. 2023;29(4).
Assoum, M.; Lau, C.L.; Thai, P.K.; Ahmed, W.; Mueller, J.F.; Thomas, K.V.; Choi, P.M.; Jackson, G.; Selvey, L.A. Wastewater Surveillance Can Function as an Early Warning System for COVID-19 in Low-Incidence Settings. Trop. Med. Infect. Dis. 2023, 8, 211. https://doi.org/10.3390/tropicalmed8040211
Lau CL, Mills DJ, Mayfield H, Gyawali N, Johnson BJ, Lu H, et al. A decision support tool for risk–benefit analysis of Japanese encephalitis vaccine in travellers. Journal of Travel Medicine. 2023.
Cavany S, Nanyonga S, Hauk C, Lim C, Tarning J, Sartorius B, Dolecek C, Caillet C, Newton PN, Cooper BS. The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance. Nature Communications. 2023 Oct 3;14(1):6153.
Rees EM, Lau CL, Kama M, Reid S, Lowe R, Kucharski AJ. Estimating the duration of antibody positivity and likely time of Leptospira infection using data from a cross-sectional serological study in Fiji. PLOS Neglected Tropical Diseases. 2022.
Bragazzi Nicola Luigi, Woldegerima Woldegebriel Assefa, Iyaniwura Sarafa Adewale, Han Qing, Wang Xiaoying, Shausan Aminath, e tal. Knowing the unknown: The underestimation of monkeypox cases. Insights and implications from an integrative review of the literature. Frontiers in Microbiology, 2022. https://doi.org/10.3389/fmicb.2022.1011049
Nilles, E. J., Paulino, C. T., de St. Aubin, M., Restrepo, A. C., Mayfield, H., Dumas, D., . . . Lau, C. L. (2022). SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection – A multistage national household survey and modelling study, Dominican Republic, June–October 2021. The Lancet Regional Health - Americas, 16, 100390. doi:https://doi.org/10.1016/j.lana.2022.100390
Nilles, E. J., Aubin, M. D. S., Dumas, D., Duke, W., Etienne, M. C., Abdalla, G., . . . Paulino, C. T. (2022). Integrated SARS-CoV-2 serological and virological screening across an acute fever surveillance platform to monitor temporal changes in anti-spike antibody levels and risk of infection during sequential waves of variant transmission — Dominican Republic, March 2021 to August 2022. medRxiv. doi:10.1101/2022.10.24.22281399
Stanhope J*, Mayfield HJ*, Guillaume JHA, Sahin O, Weinstein P, Lau CL. Synergising decision making and interventions across human health and environment: concepts for designing ana model for infectious disease transmission modeldiseases. Socio-Environmental Systems Modelling, 3, 18126. https://doi.org/10.18174/sesmo.18126
Field E., Dyda, A. Lau CL.,The Medical Journal of Australia ; 214 (8): 386-386.e1. doi: 10.5694/mja2.51019
Curtis SJ, Cutcher Z, Brett JA, Burrell S, Richards MJ, Hennessy D, Gang RF, Lau CL, Rowe SL. An evaluation of enhanced surveillance of hospitalised COVID-19 patients to inform the public health response in Victoria. Communicable Disease Intellgence 2021. doi: https://doi.org/10.33321/cdi.2020.44.98
McLure A, Lau CL, Furuya-Kanamori L. Has the effectiveness of Australia’s travel bans against China on the importation of COVID-19 been overestimated? Journal of Travel Medicine. 2020;28(2). doi: 10.1093/jtm/taaa191.
Cadavid Restrepo A, Furuya-Kanamori L, Mayfield H, Nilles E, Lau CL. Implications of a travel connectivity-based approach for infectious disease transmission risks in Oceania. BMJ Open. 2021;11(8):e046206. doi: 10.1136/bmjopen-2020-046206.
Dyda A, Fahim M, Fraser J, Kirrane M, Wong I, McNeil K, Ruge M, Lau CL, Sullivan C. Managing the Digital Disruption Associated with COVID-19-Driven Rapid Digital Transformation in Brisbane, Australia. Applied clinical informatics. 2021;12(5):1135-43. Epub 2021/12/02. doi: 10.1055/s-0041-1740190. PubMed PMID: 34852391; PubMed Central PMCID: PMCPMC8636016.
Field E, Dyda A, Hewett M, Weng H, Shi J, Curtis S, Law C, McHugh L, Sheel M, Moore J, Furuya-Kanamori L, Pillai P, Konings P, Purcell M, Stocks N, Williams G, Lau CL. Development of the COVID-19 Real-Time Information System for Preparedness and Epidemic Response (CRISPER), Australia. Front Public Health. 2021;9:753493. Epub 2021/12/04. doi: 10.3389/fpubh.2021.753493. PubMed PMID: 34858930; PubMed Central PMCID: PMCPMC8631999.
Lau CL, Mayfield HJ, Sinclair JE, Brown SJ, Waller M, Enjeti AK, Baird A, Short K, Mengersen K, Litt J. Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework. Vaccine. 2021. doi: https://doi.org/10.1016/j.vaccine.2021.10.079.
Lau CL, Galea I. Risk–benefit analysis of COVID-19 vaccines — a neurological perspective. Nature Reviews Neurology. 2022;18(2):69-70. doi: 10.1038/s41582-021-00606-5.
Mayfield HJ, Lau CL, Sinclair JE, Brown SJ, Baird A, Litt J, Vuorinen A, Short KR, Waller M, Mengersen K. Designing an evidence-based Bayesian network for estimating the risk versus benefits of AstraZeneca COVID-19 vaccine. medRxiv. 2021:2021.10.28.21265588. doi: 10.1101/2021.10.28.21265588.
Neglected tropical diseases
McLure A, Graves PM, Lau C, Shaw C, Glass K. Modelling lymphatic filariasis elimination in American Samoa: GEOFIL predicts need for new targets and six rounds of mass drug administration. Epidemics. 2022:100591.
Dickson, B.F.R.; Masson, J.J.R.; Mayfield, H.J.; Aye, K.S.; Htwe, K.M.; Roineau, M.; Andreosso, A.; Ryan, S.; Becker, L.; Douglass, J.; Graves, P.M. Bayesian Network Analysis of Lymphatic Filariasis Serology from Myanmar Shows Benefit of Adding Antibody Testing to Post-MDA Surveillance. Trop. Med. Infect. Dis. 2022, 7, 113. https://doi.org/10.3390/tropicalmed7070113
McPherson, B.; Mayfield, H.J.; McLure, A.; Gass, K.; Naseri, T.; Thomsen, R.; Williams, S.A.; Pilotte, N.; Kearns, T.; Graves, P.M.; Lau, C.L. Evaluating Molecular Xenomonitoring as a Tool for Lymphatic Filariasis Surveillance in Samoa, 2018–2019. Trop. Med. Infect. Dis. 2022, 7, 203. https://doi.org/10.3390/tropicalmed7080203.
Assoum, M.; Ortu, G.; Basáñez, M.-G.; Lau, C.; Clements, A.C.A.; Halton, K.; Fenwick, A.; Magalhães, R.J.S. Impact of a 5-Year Mass Drug Administration Programme for Soil-Transmitted Helminthiases on the Spatial Distribution of Childhood Anaemia in Burundi from 2007 to 2011. Trop. Med. Infect. Dis. 2022, 7, 307. https://doi.org/10.3390/tropicalmed7100307
Lemin, M.E.; Cadavid Restrepo, A.; Mayfield, H.J.; Lau, C.L. Spatially Explicit Environmental Factors Associated with Lymphatic Filariasis Infection in American Samoa. Trop. Med. Infect. Dis. 2022, 7, 295. https://doi.org/10.3390/tropicalmed7100295
Wangdi K, Sheel M, Fuimaono S, Graves PM, Lau CL. Lymphatic filariasis in 2016 in American Samoa: Identifying clustering and hotspots using non-spatial and three spatial analytical methods. PLoS Negl Trop Dis. 2022;16(3):e0010262.
McPherson B, Mayfield HJ, McLure A, Gass K, Naseri T, Thomsen R, Williams S, Pilotte R, Kearns T, Graves PM, Lau CL. Molecular xenomonitoring as a complement to human antigen seroprevalence for lymphatic filariasis surveillance in Samoa. Research Square 2022. 10.21203/rs.3.rs-1294399/v1
Sheel M, Lau CL, Sheridan S, Fuimaono S, Graves PM. Comparison of Immunochromatographic Test (ICT) and Filariasis Test Strip (FTS) for Detecting Lymphatic Filariasis Antigen in American Samoa, 2016. Tropical Medicine and Infectious Disease. 2021;6(3):132. PubMed PMID: doi:10.3390/tropicalmed6030132.
Graves PM, Sheridan S, Scott J, Amosa-Lei Sam F, Naseri T, Thomsen R, King CL, Lau CL. Triple-Drug Treatment Is Effective for Lymphatic Filariasis Microfilaria Clearance in Samoa. Tropical Medicine and Infectious Disease. 2021;6(2):44. PubMed PMID: doi: 10.3390/tropicalmed6020044.
Graves PM, Joseph H, Coutts SP, Mayfield HJ, Maiava F, Ah Leong-Lui TA, Tupuimatagi Toelupe P, Toeaso Iosia V, Loau S, Pemita P, Naseri T, Thomsen R, Berg Soto A, Burkot TR, Wood P, Melrose W, Aratchige P, Capuano C, Kim SH, Ozaki M, et al. Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017. Advances in parasitology. 2021;114:27-73. Epub 2021/10/27. doi: 10.1016/bs.apar.2021.03.002. PubMed PMID: 34696844.
Henderson AD, Kama M, Aubry M, Hue S, Teissier A, Naivalu T, Bechu VD, Kailawadoko J, Rabukawaqa I, Sahukhan A, Hibberd ML, Nilles EJ, Funk S, Whitworth J, Watson CH, Lau CL, Edmunds WJ, Cao-Lormeau V-M, Kucharski AJ. Interactions between timing and transmissibility explain diverse flavivirus dynamics in Fiji. Nature Communications. 2021;12(1):1671. doi: 10.1038/s41467-021-21788-y.
Aw JYH, Clarke NE, Mayfield HJ, Lau CL, Richardson A, Vaz Nery S. Novel statistical approaches to identify risk factors for soil-transmitted helminth infection in Timor-Leste. International Journal for Parasitology. 2021;51(9):729-39. doi: https://doi.org/10.1016/j.ijpara.2021.01.005.
Hedtke SM, Zendejas-Heredia PA, Graves PM, Sheridan S, Sheel M, Fuimaono SD, Lau CL, Grant WN. Genetic epidemiology of lymphatic filariasis in American Samoa after mass drug administration. International Journal for Parasitology. 2021;51(2):137-47. doi: https://doi.org/10.1016/j.ijpara.2020.08.009.
Suwannatrai AT, Thinkhamrop K, Suwannatrai K, Pratumchart K, Wangdi K, Kelly M, Cadavid Restrepo, A, Gray DJ, Clements ACA, Tangkawattana S. Opisthorchis viverrini and Strongyloides stercoralis mono-and co-infections: Bayesian geostatistical analysis in an endemic area, Thailand. Acta tropica. 2021;223:106079. doi: https://doi.org/10.1016/j.actatropica.2021.106079
Cadavid Restrepo A, Gass K, Won KY, Sheel M, Robinson K, Graves PM, Fuimaono S, Lau CL. Potential use of antibodies to provide an earlier indication of lymphatic filariasis resurgence in post-mass drug administration surveillance, American Samoa. MedRxiv. 2021. doi: doi.org/10.1101/2021.11.29.21267031
McPherson B, Mayfield HJ, McLure A, Gass K, Naseri T, Thomsen R, Williams S, Pilotte R, Kearns T, Graves PM, Lau CL. Molecular xenomonitoring as a complement to human antigen seroprevalence for lymphatic filariasis surveillance in Samoa. Research Square 2022. doi: 10.21203/rs.3.rs-1294399/v1